Gene Logic Recruits Top Talent for Key Positions in Its Nonclinical Business; Suzanne Mullins, Vice President of Quality Systems

   Tracey McNamara, DVM, Veterinary Pathologist, Was a Key Figure in
                Identifying West Nile Virus in the U.S.

   Gene Logic Inc. (NASDAQ:GLGC) announced today the appointment of
two industry professionals with responsibilities for key activities at
Gene Logic Laboratories Inc., the company's nonclinical services
subsidiary.

   --  Suzanne Mullins was named vice president, Quality Systems and
        Regulatory Compliance for Gene Logic Inc. During her 18 year
        career, Ms. Mullins has held leadership positions in quality
        systems and regulatory compliance with well-known industry
        names such as Astra Zeneca LP, Astra Merck Inc., Glaxo
        Research Institute, and, most recently, Shire Pharmaceuticals
        Group PLC. In her new position with Gene Logic, Ms. Mullins is
        responsible for all quality processes, as well as regulatory
        compliance and interaction with key regulatory bodies such as
        the U.S. Food and Drug Administration.

   --  Tracey McNamara, DVM, DACVP, has joined Gene Logic
        Laboratories, the nonclinical services division of Gene Logic,
        as a veterinary pathologist. Dr. McNamara, previously the head
        of the department of pathology at the Bronx Zoo, achieved
        renown for her work in the identification of the West Nile
        Virus outbreak in 1999. Her expertise in comparative pathology
        and zoonotic diseases--diseases that are communicable from
        animals to humans--will provide valuable capabilities for
        vaccine and toxicology studies the Company conducts for
        pharmaceutical and biopharmaceutical clients.

   "Recruiting Ms. Mullins and Dr. McNamara is a real achievement for
the Company," said V.W. Brinkerhoff III, senior vice president and
general manager, Gene Logic Laboratories. "Ms. Mullins' expertise in
quality systems and her long experience in regulatory compliance are
valuable skills our clients will appreciate. We are committed to
quality and continuous improvement; she has much to offer in building
on the systems we have in place, to the benefit of our clients and our
operations. Dr. McNamara is well-known as a veterinary pathologist for
a reason: she is an outstanding scientist. I'm certain she will add
immeasurably to the studies we conduct for our pharmaceutical and
biotechnology clients. Her work on a West Nile Virus vaccine has given
her an excellent background in vaccine development--an area of
considerable importance to our clients."

   Gene Logic Overview

   Gene Logic is leading the transformation of pharmaceutical
research and development with its extensive gene expression databases,
pioneering efforts in toxicogenomics, sophisticated bioinformatics
expertise, specialty nonclinical services testing capabilities and
cutting edge technology program for drug repositioning. Gene Logic
technologies and services are used by many of the world's top
pharmaceutical and biotechnology companies. Over 150 organizations and
government agencies have benefited from Gene Logic's diverse portfolio
of drug development services, enabling them to make more informed,
more reliable and more predictive decisions at each point in the
highly complex and costly drug development process. Founded in 1994,
Gene Logic is headquartered in Gaithersburg, Md., with additional
research and development facilities in Cambridge, Mass. and Berkeley,
Calif. The Company maintains customer support operations in Europe and
Asia and currently has about 450 employees worldwide. For more
information, visit www.genelogic.com or call toll-free -
1/800/GENELOGIC.